Search for: "Upjohn Co. v. United States" Results 61 - 80 of 92
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Apr 2012, 9:06 am by William McGrath
The Government also described the interview process with defendants, pointing out that counsel for the company gave the employees warning under Upjohn Co. v. [read post]
5 Jul 2013, 5:00 am by Bexis
Surgidev Corp., 899 P.2d 576, 591 (N.M. 1995) (“evidence of compliance with FDA regulations was properly submitted to the jury for consideration”); United Blood Services v. [read post]
21 Nov 2012, 5:00 am by Bexis
Merck & Co.,, No. 267003, 2006 WL 1628516, at *3 (Mich. [read post]
6 Jul 2007, 4:29 am
Upjohn Co., 778 A.2d 829, 836-38 (Conn. 2001); Coyle v. [read post]
25 Jan 2007, 12:48 am
United States, 17 F.3d 890, 901 (6th Cir. 1994); Albrecht v. [read post]
8 Oct 2008, 11:50 am
Upjohn Co., 778 A.2d 829, 836-37 (Conn. 2001).District of Columbia: Dyson v. [read post]
13 Aug 2009, 3:26 am
Upjohn Co., 122 F.3d 1476, 1483 (Fed. [read post]
24 May 2007, 10:40 am
Upjohn Co., 778 A.2d 829, 846 (Conn. 2001); Niemiera v. [read post]
19 Sep 2013, 9:53 am by Bexis
  In the consultation report of the neurologist states: “Neurontin is wholly appropriate in this patient. [read post]
26 May 2015, 7:42 am
  As of the time of trial, the state of the art did not include a genetic marker for SJS/TEN. [read post]
20 Aug 2010, 3:35 pm
Upjohn Co., 122 F.3d 1476, 1483 (Fed. [read post]
27 Aug 2010, 2:41 pm by Bexis
Upjohn Co., 702 S.W.2d 566, 576 (Tenn. [read post]
26 Sep 2009, 1:57 pm
See, e.g., Upjohn Co. v. [read post]